Harry W. Alcorn's most recent trade in DiaMedica Therapeutics Inc was a trade of 15,000 Voting Common Shares, no par value per share done at an average price of $3.8 . Disclosure was reported to the exchange on Sept. 15, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DiaMedica Therapeutics Inc | Harry W. Alcorn | SVP, Clinical Operations | Purchase of securities on an exchange or from another person at price $ 3.80 per share. | 15 Sep 2021 | 15,000 | 43,582 (0%) | 0% | 3.8 | 56,960 | Voting Common Shares, no par value per share |
| DiaMedica Therapeutics Inc | Harry W. Alcorn | Senior VP, Clinical Operations | Purchase of securities on an exchange or from another person at price $ 3.09 per share. | 16 Aug 2021 | 20,000 | 28,260 (0%) | 0% | 3.1 | 61,844 | Voting Common Shares, no par value per share |
| DiaMedica Therapeutics Inc | Harry W. Alcorn | Senior VP, Clinical Operations | Purchase of securities on an exchange or from another person at price $ 3.07 per share. | 16 Aug 2021 | 399 | 399 (0%) | 0% | 3.1 | 1,225 | Voting Common Shares, no par value per share |
| DiaMedica Therapeutics Inc | Harry W. Alcorn | Senior VP, Clinical Operations | Purchase of securities on an exchange or from another person at price $ 3.06 per share. | 16 Aug 2021 | 322 | 28,582 (0%) | 0% | 3.1 | 985 | Voting Common Shares, no par value per share |